Atlas Trials

Immunotherapy in Uncommon and 20ins EGFR-mut Lung Cancers

Clinical trial NCT06164574 · COMPLETED

Trial details

NCT number
NCT06164574
Sponsor
Haiquan Chen
Status
COMPLETED
Study type
OBSERVATIONAL
Lung Cancer
Start date
2022-11-01
Primary completion
2023-11-01
Enrollment
627

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.